CDER Mobilizes For Bioterrorism Threat: PDUFA Deadlines Safe, Center Says

User-fee deadlines will not be affected by FDA's efforts to respond to bioterrorism, Center for Drug Evaluation & Research Deputy Director Steven Galson, MD, told the Regulatory Affairs Professionals Society annual meeting Nov. 5 in Baltimore